Salofalk 500 Mg Gastro-Resistant Tablets
Your medicine is called Salofalk 500 mg gastro-resistant tablets, but will be referred to as Salofalk 500 mg tablets throughout the following:
Patient Information Leaflet
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
• If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet:
1. What Salofalk 500 mg tablets are and what they are used for
2. Before you take Salofalk 500 mg tablets
3. How to take Salofalk 500 mg tablets
4. Possible side effects
5. How to store Salofalk 500 mg tablets
6. Further information
Salofalk 500 mg tablets contain the active substance mesalazine, an anti-inflammatory agent used to treat inflammatory bowel disease.
Salofalk 500 mg tablets are used for:
• the treatment of acute episodes and prevention of further episodes (recurrence) of an inflammatory disease of the large intestine (colon), known by doctors as ulcerative colitis.
• If you are or have been told you are allergic (hypersensitive) to salicylic acid, to salicylates such as Aspirin® or to any of the other ingredients of Salofalk 500 mg tablets (these are listed in section 6, Further information).
• If you have a serious liver or kidney disease.
Before you start taking this medicine you should tell your doctor:
• If you have a history of problems with your lungs, particularly if you suffer from bronchial asthma.
• If you have a history of allergy to sulphasalazine, a substance related to mesalazine.
• If you suffer with problems of your liver.
• If you suffer with problems of your kidney.
During treatment your doctor may want to keep you under close medical supervision and you may need to have regular blood and urine tests.
In rare cases, in patients who have undergone bowel resection/bowel surgery in the ileocoecal area with removal of the ileocoecal valve, it has been observed that Salofalk 500mg tablets are excreted undissolved in the stool, due to an excessively rapid passage through the bowel. If you notice this occurrence in your own case, please inform your doctor.
Using other medicines
Please tell your doctor if you take or use any of the medicines mentioned below as the effects of these medicines may change (interactions):
• Certain medicines that affect blood clotting (medicines for thrombosis or to thin your blood e.g., warfarin)
• Azathioprine, 6-mercaptopurine or thioguanine (medicines used to treat immune disorders).
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. It may still be all right for you to use Salofalk 500mg tablets and your doctor will be able to decide what is suitable for you.
Ask your doctor or pharmacist for advice before taking any medicine.
You should only use Salofalk 500 mg tablets during pregnancy if your doctor tells you to.
You should also only use Salofalk 500 mg tablets during breast-feeding if your doctor tells you to, as this medicine may pass into breast milk.
There are no effects on the ability to drive and use machines.
Important information about some of the ingredients of Salofalk 500mg tablets
One Salofalk 500mg tablet contains 2.1 mmol (49 mg) sodium. If you need to be on a controlled sodium salt diet, you should take this into consideration.
Always take Salofalk 500mg tablets exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.
Method of administration
Salofalk 500mg tablets are for oral use only.
Take the tablets in the morning, at midday and in the evening, 1 hour before meals. They should be swallowed whole, not chewed, and taken with plenty of fluid.
Adults and the elderly
Prevention of recurrence/long-term treatment
1. 5 g - 3.0 g
3 x 1
3 x 1
3 x 2
There is only limited documentation for an effect in children (age 6-18 years).
Please ask your doctor about the precise dosage of Salofalk 500mg tablets for your child.
In acute episodes: to be determined individually, starting with 30-50 mg mesalazine per kg body weight per day that should be given in divided doses. The maximum dose is 75 mg mesalazine per kg body weight per day. The total dose should not exceed the maximum adult dose.
To prevent a relapse: to be determined individually, starting with15-30 mg mesalazine per kg body weight per day that should be given in divided doses. The total dose should not exceed the recommended adult dose.
It is generally recommended that half the adult dose should be given to children up to a body weight of 40 kg; and the normal adult dose to those above 40 kg.
How long you will use the medicine depends upon your condition. Your doctor will decide how long you are to continue the medication.
You should follow the treatment with Salofalk 500mg tablets regularly and consistently both during the acute episode of inflammation and also as long-term treatment, because this is the only way to achieve the desired therapeutic effect.
If you think that the effect of Salofalk 500mg tablets is too strong or too weak, talk to your doctor.
Contact a doctor if you are in doubt, so he or she can decide what to do.
If you use too much Salofalk 500mg tablets on one occasion, just take your next dose as prescribed. Do not use a smaller amount.
Do not take a larger than normal dose of Salofalk 500mg tablets next time, but continue treatment at the prescribed dosage.
Do not stop taking this product until you have talked to your doctor.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, Salofalk 500mg tablets can cause side effects, although not everybody gets them.
All medicines can cause allergic reactions although serious allergic reactions are very rare. If you get any of the following symptoms after taking this medicine, you should contact your doctor immediately:
• Allergic skin rash
• Breathing difficulties
If you experience a marked reduction of your general health, especially if accompanied by fever, and/or a sore throat and mouth, stop using these tablets and contact your doctor immediately. These symptoms can, very rarely, be due to a fall in the number of white cells in your blood (a condition called agranulocytosis) which may make you more prone to developing a serious infection. A blood test can confirm whether your symptoms are due to an effect of this medicine on your blood.
The following side effects have also been reported by patients using mesalazine:
Rare side effects (that affect less than 1 in 1,000 patients):
• Abdominal pain, diarrhoea, wind (flatulence), nausea and vomiting
• Headache, dizziness
• Chest pain, breathlessness or swollen limbs because of an effect on your heart
Very rare side effects (that affect less than 1 in 10,000 patients):
• Changes in kidney function, sometimes with swollen limbs or flank pain
• Severe abdominal pain because of acute inflammation of the pancreas
• Fever, sore throat or malaise, because of blood count changes
• Shortness of breath, cough, wheezing, lung shadow on x-ray due to allergic and/or inflammatory lung conditions
• Severe diarrhoea and abdominal pain because of an allergic reaction to this medicine within the bowel
• Skin rash or inflammation
• Muscle and joint pain
• Jaundice or abdominal pain because of liver and bile flow disorders
• Hair loss and the development of baldness
• Numbness and tingling in the hands and feet (peripheral neuropathy)
• Reversible decrease in semen production
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine.
• Keep out of the sight and reach of children.
• Do not store above 25°C.
• Do not use Salofalk 500 mg tablets after the expiry date which is stated on the carton and the blister. The expiry date refers to the last day of that month.
• This medicinal product does not require any special storage conditions.
• Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
sodium carbonate anhydrous, glycine, povidone K 25, microcrystalline cellulose, sodium carboxymethylcellulose, colloidal anhydrous silica, calcium stearate, hypromellose, macrogol 6000, eudragit L 100, talc, titanium dioxide (E 171), yellow iron oxide (E 172), Eudragit E.
Salofalk 500 mg tablets are oval, light yellow to ochre, gastro-resistant tablets, matt with smooth surface, they are not scored.
Salofalk 500 mg tablets are available in blister packs of 50 tablets.
Manufacturer and Product Licence Holder
This product is manufactured by DR. FALK PHARMA GmbH, Leineweberstrasse 5, 79 108 Freiburg, Germany. It is procured from within the EU by the Product Licence Holder: Swinghope Limited, Brandon House, Marlowe Way, Croydon CR0 4XS UK. Repackaged by Interport Limited, Brandon House, Marlowe Way, Croydon CR0 4XS UK.
PL No: 10380/1581
Leaflet revision date: 21/05/2015
Salofalk is registered trademark of Dr. Falk Pharma GmbH, Germany.
Each gastro-resistant tablet contains 500 mg mesalazine.